Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2021EurosurveillanceOpen Access

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYaniv LustigNZNeta S. ZuckermanINItal Nemet

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lustig et al. (2021) studied this question.

synapsesocial.com/papers/6a97b03e761fafb16923a2e2https://doi.org/10.2807/1560-7917.es.2021.26.26.2100557
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India2021 · 662 citations
  2. 2Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.3512021 · 226 citations
  3. 3BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants2021 · 110 citations
  4. 4Nextstrain: real-time tracking of pathogen evolution2018 · 3,517 citations
  5. 5Fast and accurate short read alignment with Burrows–Wheeler transform2009 · 64,082 citations